By using a syngeneic malignant glioma tumor model, we set out to determine whether a combined anti‐VEGFR and anti‐TGF‐β1 treatment could significantly normalize tumor vasculatures and reduce collagen density within the ECM. The gene discussed is KDR; the disease is neoplasm.